FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....